We report that in the PPP1R13L promoter region, the methylation levels of some CpG sites in peripheral blood leukocytes differed between lung cancer cases and controls and that hypomethylation was observed more often in lung cancer cases than in controls. This evidence concerns the gene PPP1R13L and lung cancer.